NSBCX
Price
$67.38
Change
-$0.09 (-0.13%)
Updated
Oct 21 closing price
Net Assets
6.8B
VSTSX
Price
$317.25
Change
+$0.04 (+0.01%)
Updated
Oct 21 closing price
Net Assets
2.02T
Interact to see
Advertisement

NSBCX vs VSTSX

Header iconNSBCX vs VSTSX Comparison
Open Charts NSBCX vs VSTSXBanner chart's image
Nuveen Dividend Growth C
Price$67.38
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets6.8B
Vanguard Total Stock Mkt Idx Instl Sel
Price$317.25
Change+$0.04 (+0.01%)
VolumeN/A
Net Assets2.02T
NSBCX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
NSBCX vs. VSTSX commentary
Oct 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSBCX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. NSBCX (6.8B). VSTSX pays higher dividends than NSBCX: VSTSX (1.15) vs NSBCX (0.13). NSBCX was incepted earlier than VSTSX: NSBCX (20 years) vs VSTSX (9 years). NSBCX (1.67) is less costly to investors than VSTSX (0.01). NSBCX is a more actively managed with annual turnover of: 11.00 vs. VSTSX (2.00). NSBCX has a lower initial minimum investment than VSTSX: NSBCX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 15.03 vs. NSBCX (1.96). VSTSX return over 5 years is better than : 88.68 vs. NSBCX (52.91).
NSBCXVSTSXNSBCX / VSTSX
Total Expense Ratio1.670.0116,700%
Annual Report Gross Expense Ratio1.670.0116,700%
Fund Existence20 years9 years-
Gain YTD10.03114.30570%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.8B2.02T0%
Annual Yield % from dividends0.131.1511%
Returns for 1 year1.9615.0313%
Returns for 3 years42.2577.0955%
Returns for 5 years52.9188.6860%
Returns for 10 years96.77N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWBX91.90N/A
N/A
American Funds New World R2
FCEUX19.60N/A
N/A
Franklin U.S. Core Equity Advisor
GEIZX19.20N/A
N/A
GuideStone Funds Growth Equity Index Inv
HBGHX14.13N/A
N/A
Hartford Healthcare HLS IB
BEXUX19.90-0.09
-0.47%
Baron Emerging Markets R6